Valuation: Codexis, Inc.

Market Cap 118M 105M 96.65M 87.83M 165M 11.18B 169M 1.16B 463M 5.92B 444M 434M 18.74B P/E 2026 *
-2.87x
P/E 2027 * -3.74x
Enterprise Value 118M 105M 96.65M 87.83M 165M 11.18B 169M 1.16B 463M 5.92B 444M 434M 18.74B EV / Sales 2026 *
1.6x
EV / Sales 2027 * 1.35x
Free-Float
92.89%
Yield 2026 *
-
Yield 2027 * -
1 week-15.62%
Current month-9.24%
1 month-20.59%
3 months-25.52%
6 months-59.55%
Current year-33.74%
1 week 1.04
Extreme 1.04
1.3
1 month 1.04
Extreme 1.04
1.44
Current year 0.96
Extreme 0.9583
2.98
1 year 0.96
Extreme 0.9583
2.98
3 years 0.96
Extreme 0.9583
6.08
5 years 0.96
Extreme 0.9583
42.01
10 years 0.96
Extreme 0.9583
42.01
Manager TitleAgeSince
Chief Executive Officer 59 07/11/2025
Director of Finance/CFO 59 30/09/2024
Chief Tech/Sci/R&D Officer 56 05/05/2020
Director TitleAgeSince
Director/Board Member 66 01/03/2016
Director/Board Member 59 07/11/2025
Chairman 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
10/12/26 A Sell

Chief Financial Officer

-6,335 0.0058%
10/12/26 A Sell

Chief Executive Officer

-6,335 0.0058%
2/23/26 A Free

Chief Financial Officer

316,100 0.3500%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-15.62%-52.21%-44.04% 118M
+10.00%+5.18%+54.35%+71.20% 60.57B
+1.44%+4.06%+22.70%+101.03% 55.51B
+3.32%+4.11%+14.82%+75.04% 55.22B
+0.46%-2.86%+23.34%+33.77% 43.27B
+6.42%+3.20%+21.14%+105.56% 40.36B
+2.82%+7.24%+236.59%+801.17% 41.63B
-3.79%+19.39%+91.90%+77.13% 33.29B
+5.32%+6.04%+20.27%+52.98% 32.27B
+5.32%+15.84%-40.93%+342.66% 22.91B
Average +3.13%+2.56%+39.20%+161.65% 38.51B
Weighted average by Cap. +3.72%+4.05%+51.54%+169.45%

Financials

2026 *2027 *
Net sales 73.88M 65.84M 60.38M 54.87M 103M 6.98B 106M 722M 289M 3.7B 277M 271M 11.71B 87.69M 78.14M 71.66M 65.12M 122M 8.29B 125M 856M 343M 4.39B 329M 322M 13.89B
Net income -37.19M -33.14M -30.39M -27.62M -51.92M -3.51B -53.1M -363M -146M -1.86B -140M -137M -5.89B -29.67M -26.44M -24.25M -22.04M -41.43M -2.8B -42.37M -290M -116M -1.48B -111M -109M -4.7B
Net Debt - -
Projected Income Statement - Annual - Codexis, Inc.
Logo Codexis, Inc.
Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.
Employees
146
Date Price Change Volume
04/11/26 $1.090 +0.93% 658,193
03/11/26 $1.080 +3.35% 613,169
02/11/26 $1.045 -12.18% 1,133,456
30/10/26 $1.190 -2.46% 789,468
29/10/26 $1.220 -3.17% 917,303
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
MarketScreener Ratings - Codexis, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
1.080USD
Average target price
6.143USD
Spread / Average Target
+468.78%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Codexis, Inc.
  1. Stock Market
  2. Stocks
  3. CDXS Stock